NAM
IQMD

Nexpoint Asset Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Nexpoint Asset Management’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-260,000
Closed -$2.57M – 217
2021
Q4 		$2.57M Buy
+260,000
New +$2.57M 0.36% 44

Other funds holding IQMD

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nexpoint Asset Management's IQMD Position: Q1 2022 in Review

Nexpoint Asset Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2022, closing a stake of 260,000 shares — an estimated $2.57M sold.

Nexpoint Asset Management first reported a position in IQMD in Q4 2021 and held it in 1 quarter. The position peaked at $2.57M in Q4 2021. 56 funds tracked by Wall St. Rank hold IQMD as of Q1 2022.

  • Nexpoint Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 260,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2022, an estimated $2.57M.
  • Nexpoint Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • Nexpoint Asset Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $2.57M in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.